Dr Alvin   Kamili
Conjoint Lecturer

Dr Alvin Kamili

Bachelor of Medical Science (Hons I), UNSW Sydney

PhD, University of Sydney

medicine-health
Sch Women's&Children's Health

Dr Alvin Kamili is a senior research officer and preclinical drug testing core team coordinator in the Zero Childhood Cancer - Personalised Medicine Program at the Children’s Cancer Institute, Sydney, Australia. He mainly focuses on the establishment of preclinical models for neuroblastoma, a disease in which patients frequently relapse with incurable, drug resistant disease, resulting in long-term survival rates below 50%. His works aim to implement personalised medicine approach to improve patient survival rates through identifying molecular aberration underlying cancer progression in individual patient, screening ex vivo tumour cells against library of anticancer drugs, and developing improved pre-clinical testing models.

Location
Children's Cancer Institute Level 1, Lowy Cancer Research Centre The University of New South Wales, Sydney, NSW 2052, Australia

Publications

  • Book Chapters | 2014
    Dr Alvin Kamili
    Kamili A; Byrne JA, 2014, 'Lipidomics in Breast Cancer', in Barh D (ed.), Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy, Springer, India, pp. 225 - 244, http://dx.doi.org/10.1007/978-81-322-0843-3_11
  • Journal articles | 2021
    Dr Alvin Kamili
    Xiao L; Somers K; Murray J; Pandher R; Karsa M; Ronca E; Bongers A; Terry R; Ehteda A; Gamble LD; Issaeva N; Leonova KI; O'Connor A; Mayoh C; Venkat P; Quek H; Brand J; Kusuma FK; Pettitt JA; Mosmann E; Kearns A; Eden G; Alfred S; Allan S; Zhai L; Kamili A; Gifford AJ; Carter DR; Henderson MJ; Fletcher JI; Marshall G; Johnstone RW; Cesare AJ; Ziegler DS; Gudkov AV; Gurova KV; Norris MD; Haber M, 2021, 'Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma.', Clin Cancer Res, vol. 27, pp. 4338 - 4352, http://dx.doi.org/10.1158/1078-0432.CCR-20-2357
    Journal articles | 2021
    Dr Alvin Kamili
    Chen J; Nelson C; Wong M; Tee AE; Liu PY; La T; Fletcher JI; Kamili A; Mayoh C; Bartenhagen C; Trahair TN; Xu N; Jayatilleke N; Wong M; Peng H; Atmadibrata B; Cheung BB; Lan Q; Bryan TM; Mestdagh P; Vandesompele J; Combaret V; Boeva V; Wang JY; Janoueix-Lerosey I; Cowley MJ; MacKenzie KL; Dolnikov A; Li J; Polly P; Marshall GM; Reddel RR; Norris MD; Haber M; Fischer M; Zhang XD; Pickett HA; Liu T, 2021, 'Targeted therapy of TERT-rearranged neuroblastoma with BET bromodomain inhibitor and proteasome inhibitor combination therapy', Clinical Cancer Research, vol. 27, pp. 1438 - 1451, http://dx.doi.org/10.1158/1078-0432.CCR-20-3044
    Journal articles | 2021
    Dr Alvin Kamili
    Xie J; Kumar A; Dolman MEM; Mayoh C; Khuong-Quang DA; Cadiz R; Wong-Erasmus M; Mould EVA; Grebert-Wade D; Barahona P; Kamili A; Tsoli M; Failes TW; Chow SO; Bhatia K; Marshall GM; Ziegler DS; Haber M; Lock RB; Tyrrell V; Lau L; Athanasatos P; Gifford AJ, 2021, 'The important role of routine cytopathology in pediatric precision oncology', Cancer Cytopathology, http://dx.doi.org/10.1002/cncy.22448
    Journal articles | 2021
    Dr Alvin Kamili
    Grohmann C; Walker F; Devlin M; Luo MX; Chüeh AC; Doherty J; Vaillant F; Ho GY; Wakefield MJ; Weeden CE; Kamili A; Murray J; Po’uha ST; Weinstock J; Kane SR; Faux MC; Broekhuizen E; Zheng Y; Shield-Artin K; Kershaw NJ; Tan CW; Witchard HM; Ebert G; Charman SA; Street I; Kavallaris M; Haber M; Fletcher JI; Asselin-Labat ML; Scott CL; Visvader JE; Lindeman GJ; Watson KG; Burgess AW; Lessene G, 2021, 'Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors', Cell Death and Disease, vol. 12, http://dx.doi.org/10.1038/s41419-020-03269-0
    Journal articles | 2020
    Dr Alvin Kamili
    Huynh T; Murray J; Flemming CL; Kamili A; Hofmann U; Cheung L; Roundhill EA; Yu DMT; Webber HT; Schwab M; Henderson MJ; Haber M; Norris MD; Fletcher JI, 2020, 'CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth', Biochemical Pharmacology, vol. 172, http://dx.doi.org/10.1016/j.bcp.2019.113770
    Journal articles | 2020
    Dr Alvin Kamili
    Tee AE; Ciampa OC; Wong M; Fletcher JI; Kamili A; Chen J; Ho N; Sun Y; Carter DR; Cheung BB; Marshall GM; Liu PY; Liu T, 2020, 'Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastoma', International Journal of Cancer, vol. 147, pp. 1928 - 1938, http://dx.doi.org/10.1002/ijc.32936
    Journal articles | 2020
    Dr Alvin Kamili
    Gao J; Jung MS; Mayoh C; Venkat P; Hannan KM; Fletcher JI; Kamili A; Gifford AJ; Kusnadi EP; Pearson RB; Hannan RD; Haber M; Norris MD; Somers K; Henderson MJ, 2020, 'Suppression of ABCE1-mediated mRNA translation limits N-MYC-driven cancer progression', Cancer Research, vol. 80, pp. 3706 - 3718, http://dx.doi.org/10.1158/0008-5472.CAN-19-3914
    Journal articles | 2020
    Dr Alvin Kamili
    Vittorio O, 2020, 'Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation', Theranostics, http://dx.doi.org/10.7150/thno.42602
    Journal articles | 2020
    Dr Alvin Kamili
    Kamili A; Gifford AJ; Li N; Mayoh C; Chow S-O; Failes TW; Eden GL; Cadiz R; Xie J; Lukeis RE; Norris MD; Haber M; McCowage GB; Arndt GM; Trahair TN; Fletcher JI, 2020, 'Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy', British Journal of Cancer, http://dx.doi.org/10.1038/s41416-019-0682-4
    Journal articles | 2020
    Dr Alvin Kamili
    Kamili A; Atkinson C; Trahair TN; Fletcher JI, 2020, 'Mouse models of high-risk neuroblastoma', Cancer and Metastasis Reviews, http://dx.doi.org/10.1007/s10555-020-09855-0
    Journal articles | 2019
    Dr Alvin Kamili
    Gamble LD; Purgato S; Murray J; Xiao L; Yu DMT; Hanssen KM; Giorgi FM; Carter DR; Gifford AJ; Valli E; Milazzo G; Kamili A; Mayoh C; Liu B; Eden G; Sarraf S; Allan S; Giacomo SD; Flemming CL; Russell AJ; Cheung BB; Oberthuer A; London WB; Fischer M; Trahair TN; Fletcher JI; Marshall GM; Ziegler DS; Hogarty MD; Burns MR; Perini G; Norris MD; Haber M, 2019, 'Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma', Science Translational Medicine, vol. 11, http://dx.doi.org/10.1126/scitranslmed.aau1099
    Journal articles | 2015
    Dr Alvin Kamili
    Kamili A; Roslan N; Frost S; Cantrill LC; Wang D; Della-Franca A; Bright RK; Groblewski GE; Straub BK; Hoy AJ; Chen Y; Byrne JA, 2015, 'TPD52 expression increases neutral lipid storage within cultured cells', Journal of Cell Science, vol. 128, pp. 3223 - 3238, http://dx.doi.org/10.1242/jcs.167692
    Journal articles | 2013
    Dr Alvin Kamili
    Chen Y; Kamili A; Hardy JR; Groblewski GE; Khanna KK; Byrne JA, 2013, 'Tumor protein D52 represents a negative regulator of ATM protein levels', Cell Cycle, vol. 12, pp. 3083 - 3097, http://dx.doi.org/10.4161/cc.26146
    Journal articles | 2013
    Dr Alvin Kamili
    Chung RWS; Kamili A; Tandy S; Weir JM; Gaire R; Wong G; Meikle PJ; Cohn JS; Rye KA, 2013, 'Dietary Sphingomyelin Lowers Hepatic Lipid Levels and Inhibits Intestinal Cholesterol Absorption in High-Fat-Fed Mice', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0055949
    Journal articles | 2010
    Dr Alvin Kamili
    Cohn JS; Kamili A; Wat E; Chung RWS; Tandy S, 2010, 'Dietary phospholipids and intestinal cholesterol absorption', Nutrients, vol. 2, pp. 116 - 127, http://dx.doi.org/10.3390/nu2020116
    Journal articles | 2010
    Dr Alvin Kamili
    Cohn JS; Kamili A; Wat E; Chung RWS; Tandy S, 2010, 'Reduction in intestinal cholesterol absorption by various food components: Mechanisms and implications', Atherosclerosis Supplements, vol. 11, pp. 45 - 48, http://dx.doi.org/10.1016/j.atherosclerosissup.2010.04.004
    Journal articles | 2010
    Dr Alvin Kamili
    Kamili A; Wat E; Chung RW; Tandy S; Weir JM; Meikle PJ; Cohn JS, 2010, 'Hepatic accumulation of intestinal cholesterol is decreased and fecal cholesterol excretion is increased in mice fed a high-fat diet supplemented with milk phospholipids', Nutrition and Metabolism, vol. 7, http://dx.doi.org/10.1186/1743-7075-7-90
    Journal articles | 2010
    Dr Alvin Kamili
    Tandy S; Chung RWS; Kamili A; Wat E; Weir JM; Meikle PJ; Cohn JS, 2010, 'Hydrogenated phosphatidylcholine supplementation reduces hepatic lipid levels in mice fed a high-fat diet', Atherosclerosis, vol. 213, pp. 142 - 147, http://dx.doi.org/10.1016/j.atherosclerosis.2010.07.050
    Journal articles | 2010
    Dr Alvin Kamili
    Kamili A; Wat E; Tandy S; Chung WSR; Brown A; Rowney M; Cohn JS, 2010, 'P264 DIETARY MILK PHOSPHOLIPID IMPROVES DIET-INDUCED HEPATIC STEATOSIS IN MICE BY REDUCING INTESTINAL CHOLESTEROL ABSORPTION', Atherosclerosis Supplements, vol. 11, pp. 72 - 72, http://dx.doi.org/10.1016/s1567-5688(10)70331-7
    Journal articles | 2010
    Dr Alvin Kamili
    Tandy S; Chung RWS; Wat E; Kamili A; Griinari M; Berge K; Cohn JS, 2010, 'Dietary krill oil significantly reduces hepatic steatosis, glycaemia and hypercholesterolaemia in high-fat-fed mice', PROCEEDINGS OF THE NUTRITION SOCIETY, vol. 69, pp. E48 - E48, http://dx.doi.org/10.1017/S0029665109992369
    Journal articles | 2009
    Dr Alvin Kamili
    Tandy S; Chung RWS; Wat E; Kamili A; Berge K; Griinari M; Cohn JS, 2009, 'Dietary Krill Oil Supplementation Reduces Hepatic Steatosis, Glycemia, and Hypercholesterolemia in High-Fat-Fed Mice', JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 57, pp. 9339 - 9345, http://dx.doi.org/10.1021/jf9016042
    Journal articles | 2009
    Dr Alvin Kamili
    Wat E; Tandy S; Kapera E; Kamili A; Chung RWS; Brown A; Rowney M; Cohn JS, 2009, 'Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet', Atherosclerosis, vol. 205, pp. 144 - 150, http://dx.doi.org/10.1016/j.atherosclerosis.2008.12.004
    Journal articles | 2009
    Dr Alvin Kamili
    Tandy S; Chung R; Wat E; Kamili A; Berge K; Griinari M; Cohn J, 2009, 'Abstract: 1031 DIETARY KRILL OIL SUPPLEMENTATION SIGNIFICANTLY REDUCES HEPATOMEGALY, HEPATIC STEATOSIS AND HYPERCHOLESTEROLEMIA IN HIGH-FAT FED MICE', Atherosclerosis Supplements, vol. 10, pp. e395 - e395, http://dx.doi.org/10.1016/s1567-5688(09)70387-3
    Journal articles | 2009
    Dr Alvin Kamili
    Cohn J; Tandy S; Wat E; Kamili A; Chung R; Rowney M; Brown A, 2009, 'Abstract: 601 DIETARY MILK PHOSPHOLIPID AS A CARDIOVASCULAR NUTRACEUTICAL', Atherosclerosis Supplements, vol. 10, pp. e354 - e354, http://dx.doi.org/10.1016/s1567-5688(09)70350-2
    Journal articles | 2008
    Dr Alvin Kamili
    Cohn JS; Wat E; Kamili A; Tandy S, 2008, 'Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease', Current Opinion in Lipidology, vol. 19, pp. 257 - 262, http://dx.doi.org/10.1097/MOL.0b013e3282ffaf96
    Journal articles | 2007
    Dr Alvin Kamili
    Kim WS; Rahmanto A; Kamili A; Rye K; Guillemin GJ; Gelissen I; Jessup W; Hill A; Garner B, 2007, 'Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation', The Journal of Biological Chemistry, vol. 282, pp. 2851 - 2861, http://dx.doi.org/10.1074/jbc.M607831200
  • Conference Papers | 2021
    Dr Alvin Kamili
    Vijayasubhash V, 2021, 'Analysis of DNA minimal residual disease markers in pediatric solid cancers using quantitative real time PCR and droplet digital PCR', in Analysis of DNA minimal residual disease markers in pediatric solid cancers using quantitative real time PCR and droplet digital PCR, presented at AACR 2021, http://dx.doi.org/10.1158/1538-7445.AM2021-639
    Conference Abstracts | 2020
    Dr Alvin Kamili
    Atkinson C; Tactacan C; Kamili A; Saletta F; Gana C; Eden G; Mayoh C; Lock R; Norris M; Haber M; Gifford A; Trahair T; Fletcher J, 2020, 'Abstract A35: P-Glycoprotein is a resistance mechanism for conventional induction chemotherapy but not ALK inhibitors in high-risk neuroblastoma', in Poster Presentations - Proffered Abstracts, American Association for Cancer Research, presented at Abstracts: AACR Special Conference on the Advances in Pediatric Cancer Research; September 17-20, 2019; Montreal, QC, Canada, http://dx.doi.org/10.1158/1538-7445.pedca19-a35
    Conference Abstracts | 2019
    Dr Alvin Kamili
    Haber M; Gamble L; Xiao L; Pandher R; Somers K; Murray J; Khan A; Yu D; Franshaw L; Burns MR; Tsoli M; Ehteda A; Cesare A; O'Connor A; Mussai F; de Santo C; Cheng P; Korotchkina L; Gurova K; Tyrrell V; Mould E; Lau L; Dong AKQ; Mayoh C; Arndt G; Barahona P; Failes T; Fletcher J; Fuentes-Bolanos N; Gauthier M-E; Gifford A; Grebert-Wade D; Kamili A; Kumar A; Nagabushan S; O'Brien T; Strong P; Sherstyuk A; Thomas D; Trahair T; Tucker K; Warby M; Wong M; Xie J; Evans K; Lock R; Chernova OB; Henderson M; Gudkov AV; Ekert P; Cowley MJ; Marshall GM; Ziegler DS; Norris MD, 2019, 'Molecular targeted therapies and precision medicine for children with neuroblastoma and other refractory malignancies', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Montreal, CANADA, Vol. 80, pp. 23 - 24, presented at AACR Special Conference on the Advances in Pediatric Cancer Research, Montreal, CANADA, 17 September 2019 - 20 September 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000551367400013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Dr Alvin Kamili
    Kamili A; Gifford AJ; Li N; Mayoh C; Eden GL; Xie J; Lukeis RE; Norris MD; Haber M; McCowage G; Trahair TN; Fletcher JI, 2019, 'Abstract 2884: Establishment of patient-derived xenograft models for high-risk neuroblastoma', in Tumor Biology, American Association for Cancer Research, presented at Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA, http://dx.doi.org/10.1158/1538-7445.sabcs18-2884
    Conference Abstracts | 2019
    Dr Alvin Kamili
    Mould EV; Lau L; Arndt G; Barahona P; Cowley MJ; Ekert P; Failes T; Fletcher J; Gifford A; Grebert-Wade D; Haber M; Kamili A; Kumar A; Lock RB; Marshall GM; Mayoh C; Norris M; O'Brien T; Quang DAK; Strong P; Sherstyuk A; Trahair T; Tsoli M; Tucker K; Warby M; Wong M; Xie J; Ziegler DS; Tyrrell V, 2019, 'Zero Childhood Cancer: A comprehensive precision medicine platform for children with high-risk cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Atlanta, GA, Vol. 79, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), Atlanta, GA, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.AM2019-3111
    Conference Abstracts | 2019
    Dr Alvin Kamili
    Atkinson C; Tactacan CM; Kamili A; Saletta F; Gana C; Eden GL; Mayoh C; Lock RB; Norris MD; Haber M; Gifford AJ; Trahair TN; Fletcher JI, 2019, 'Abstract 4741: Re-evaluating the role of P-glycoprotein in the resistance of high-risk neuroblastoma to standard-of-care chemotherapies', in Experimental and Molecular Therapeutics, American Association for Cancer Research, presented at Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA, http://dx.doi.org/10.1158/1538-7445.am2019-4741
    Conference Abstracts | 2019
    Dr Alvin Kamili
    Atkinson C; Tactacan C; Kamili A; Saletta F; Gana C; Eden G; Mayoh C; Lock R; Norris M; Haber M; Gifford A; Trahair T; Fletcher J, 2019, 'P-Glycoprotein is a resistance mechanism for conventional induction chemotherapy but not ALK inhibitors in high-risk neuroblastoma', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Montreal, CANADA, Vol. 80, pp. 61 - 61, presented at AACR Special Conference on the Advances in Pediatric Cancer Research, Montreal, CANADA, 17 September 2019 - 20 September 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000551367400079&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Dr Alvin Kamili
    Atkinson C; Tactacan CM; Kamili A; Saletta F; Gana C; Eden GL; Mayoh C; Lock RB; Norris MD; Haber M; Gifford AJ; Trahair TN; Fletcher JI, 2019, 'Re-evaluating the role of P-glycoprotein in the resistance of high-risk neuroblastoma to standard-of-care chemotherapies', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Atlanta, GA, Vol. 79, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), Atlanta, GA, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.SABCS18-4741
    Conference Abstracts | 2019
    Dr Alvin Kamili
    Kamili A; Gifford AJ; Li N; Mayoh C; Eden GL; Xie J; Lukeis RE; Norris MD; Haber M; McCowage G; Trahair TN; Fletcher JI, 2019, 'Establishment of patient-derived xenograft models for high-risk neuroblastoma', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Atlanta, GA, Vol. 79, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), Atlanta, GA, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.AM2019-2884
    Conference Abstracts | 2018
    Dr Alvin Kamili
    Mould E; Lau L; Arndt G; Barahona P; Cowley M; Ekert P; Failes T; Fletcher J; Gifford A; Haber M; Kamili A; Kumar A; Lock R; Marshall G; Mayoh C; Mead S; Norris M; O'Brien T; Pinese M; Dong AKQ; Trahair T; Tsoli M; Tucker K; Warby M; Wong M; Xie J; Ziegler D; Tyrrell V, 2018, 'Zero Childhood Cancer: A comprehensive precision medicine platform for children with high-risk cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Chicago, IL, Vol. 78, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), Chicago, IL, 14 April 2018 - 18 April 2018, http://dx.doi.org/10.1158/1538-7445.AM2018-LB-138
    Conference Papers | 2014
    Dr Alvin Kamili
    Chen Y; Roslan N; Frost S; Kamili A; Cantrill L; Byrne JA, 2014, 'The target and the targeted-Tumor protein D52 (TPD52) and cancer', in INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, SPANDIDOS PUBL LTD, pp. S39 - S39, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000341276000139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2010
    Dr Alvin Kamili
    Kamili A; Wat E; Tandy S; Chung WSR; Brown A; Rowney M; Cohn JS, 2010, 'DIETARY MILK PHOSPHOLIPID IMPROVES DIET-INDUCED HEPATIC STEATOSIS IN MICE BY REDUCING INTESTINAL CHOLESTEROL ABSORPTION', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Hamburg, GERMANY, pp. 72 - 72, presented at 78th Congress of the European-Atherosclerosis-Society, Hamburg, GERMANY, 20 June 2010 - 23 June 2010, http://dx.doi.org/10.1016/j.atherosclerosissup.2010.04.022
    Conference Papers | 2010
    Dr Alvin Kamili
    Kamili A; Wat E; Tandy S; Chung WSR; Brown A; Rowney M; Cohn JS, 2010, 'Dietary Milk Phospholipid Improves Diet-Induced Hepatic Steatosis In Mice By Reducing Intestinal Cholesterol Absorption', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Rotterdam, NETHERLANDS, pp. 72 - 73, presented at 2nd International Symposium of Chylomicrons in Disease, Rotterdam, NETHERLANDS, 02 June 2010 - 05 June 2010, http://dx.doi.org/10.1016/j.atherosclerosissup.2010.04.022
    Conference Papers | 2010
    Dr Alvin Kamili
    Kamili A; Wat E; Tandy S; Chung RW; Brown A; Rowney M; Goulburn M; Cohn JS, 2010, 'Dietary Milk Phospholipid Improves Diet-Induced Hepatic Steatosis in Mice by Reducing Intestinal Cholesterol Absorption', in ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, San Francisco, CA, pp. E241 - E241, presented at Scientific Sessions on Arteriosclerosis, Thrombosis and Vascular Biology, San Francisco, CA, 08 April 2010 - 10 April 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283234800267&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2009
    Dr Alvin Kamili
    Tandy S; Chung R; Wat E; Kamili A; Berge K; Griinari M; Cohn J, 2009, 'DIETARY KRILL OIL SUPPLEMENTATION SIGNIFICANTLY REDUCES HEPATOMEGALY, HEPATIC STEATOSIS AND HYPERCHOLESTEROLEMIA IN HIGH-FAT FED MICE', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207957101042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2009
    Dr Alvin Kamili
    Cohn J; Tandy S; Wat E; Kamili A; Chung R; Rowney M; Brown A, 2009, 'DIETARY MILK PHOSPHOLIPID AS A CARDIOVASCULAR NUTRACEUTICAL', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207957101001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Awards

Grants

NHMRC Ideas Grant, 2020-2021, $286,900, Improving induction therapy for high-risk neuroblastoma through bypass or inhibition of P-glycoprotein (APP1182974) 

Media